NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Profit After Tax (2021 - 2024)

NeuroSense Therapeutics' (NRSN) quarterly Profit After Tax came in at -$1.8 million in Q4 2024, up 43.49% year-over-year from -$1.3 million in Q1 2024, and up 87.72% quarter-over-quarter from -$14.7 million in Q3 2024.

Analysis

NeuroSense Therapeutics (NRSN) Profit After Tax (2021 - 2024) Analysis & Trends

NeuroSense Therapeutics has disclosed Profit After Tax across 4 years of filings, most recently posting -$1.8 million for Q4 2024.

  • In Q4 2024, Profit After Tax rose 43.49% year-over-year to -$1.8 million; the TTM figure through Dec 2024 stood at -$10.2 million (down 1.02% YoY), while the FY2025 annual figure was -$11.1 million, down 8.96% from the prior year.
  • Profit After Tax came in at -$1.8 million for Q4 2024 at NeuroSense Therapeutics, up from -$14.7 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $11.7 million in Q2 2024 to a low of -$15.4 million in Q3 2022.
  • Average Profit After Tax over 4 years is -$1.8 million, with a median of -$2.7 million recorded in 2022.
  • The largest YoY upside for Profit After Tax was 419.94% in 2024 against a maximum downside of 4091.43% in 2024.
  • Over 4 years, Profit After Tax stood at $7.2 million in 2021, then tumbled by 118.18% to -$1.3 million in 2022, then slumped by 144.78% to -$3.2 million in 2023, then soared by 43.49% to -$1.8 million in 2024.
  • Per Business Quant data, the three most recent Profit After Tax figures were -$1.8 million in Q4 2024, -$14.7 million in Q3 2024, and $11.7 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 1.30 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -782.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 472.00 Mn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 164.49 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -290.61 Mn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.80 Mn
Sep 30, 2024 -14.67 Mn
Jun 30, 2024 11.67 Mn
Mar 31, 2024 -5.40 Mn
Dec 31, 2023 -3.19 Mn
Sep 30, 2023 -350,000.00
Jun 30, 2023 -3.65 Mn
Mar 31, 2023 -2.92 Mn
Dec 31, 2022 -1.30 Mn
Sep 30, 2022 -15.39 Mn
Jun 30, 2022 8.91 Mn
Mar 31, 2022 -2.72 Mn
Dec 31, 2021 7.16 Mn
API Access

NeuroSense Therapeutics Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=NRSN&period=max&api_key=YOUR_API_KEY